Biopharma in 2020 has shown what it can achieve when it works at its best. How can the industry build on this renewed sense of purpose in the years ahead? McKinsey biopharma 2020 3 Overarching trends Operating under a spotlight - expectation of innovationNavigating protracted economic uncertainty -...
Source: mckinsey.com
“Towards a dementia-inclusive society: WHO toolkit for dementia-friendly initiatives”, launched today, is WHO’s latest response for establishing and scaling-up dementia-friendly initiatives globally. The toolkit helps countries raise public awareness and understanding of dementia to support people...
Source: who.int
"These [polluter elite] are people who fly most, drive the biggest cars most and live in the biggest homes which they can easily afford to heat, so they tend not to worry if they’re well insulated or not. … They’re also the sort of people who could really afford good insulation and solar panels...
Source: bbc.com
Scaling Kubernetes to 7,500 Nodes: We've scaled Kubernetes clusters to 7,500 nodes, producing a scalable infrastructure for large models like GPT-3, CLIP, and DALL·E, but also for rapid small-scale iterative research such as Scaling Laws for Neural Language Models. Scaling a single Kubernetes cluster...
Source: openai.com
"Startups are better at detecting and unlocking emerging and latent demand. But they often stumble at scaling their proof of concept, not only because they’re often doing it for the first time, but also because the skills necessary for creating are not the same as scaling." Eddie Yoon, Steve Hughes....
Source: hbr.org
"In its ongoing effort to make MOOCs more and more like traditional
education, Coursera has launched 'mentor-guided courses' for the cost of
$US 248." I like Stephen Downes and the way he pokes fun at the big MOOC companies. Their aim though is simply to try and monetize their courses. The mentor...
Source: downes.ca